Blueprint Medicines (NASDAQ:BPMC) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Blueprint Medicines (BPMC) operate in?

Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Blueprint Medicines Stock (NASDAQ: BPMC) stock price, news, charts, stock research, profile.

Open	$105.87
Close	$110.05
Volume / Avg.	972.27K / 720.04K
Day Range	$104.73 - $110.28
52 Wk Range	72.24 - 121.90
Market Cap	$6.99B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	9.04%
Days to Cover	8.43

Recent News

IonQ, H&E Equipment Services And ImmunityBio Are Among Top Mid Cap Gainers Last Week (Jan 13-Jan 17): Are The Others In Your Portfolio?

Explore this week's top-performing mid-cap stocks, including H&E Equipment Services' impressive 100.59% surge following an acquisition announcement by United Rentals. Discover why stocks like SEMrush and Blueprint Medicines also experienced significant gains, impacting investment portfolios positively.

Lekha Gupta

Intra-Cellular Therapies, Standard BioTools, SI-BONE And Other Big Stocks Moving Higher On Monday

Avi Kapoor

Blood Cancer-Focused Blueprint Medicines Could Be 'Attractive Target For Partnerships': Analyst

JP Morgan initiates coverage on Blueprint Medicines, highlighting Ayvakit's significant growth, 2024 revenue forecast, and potential strategic opportunities.

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Oct 24

Nov 24

Dec 24

Jan

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.3

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$105.87
Close	$110.05
Volume / Avg.	972.27K / 720.04K
Day Range	$104.73 - $110.28
52 Wk Range	72.24 - 121.90
Market Cap	$6.99B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	74
Short Interest	9.04%
Days to Cover	8.43

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Blueprint Medicines (BPMC) stock?

You can purchase shares of Blueprint Medicines (NASDAQ:BPMC) through any online brokerage.

View our list of the best stock brokerages

Who are Blueprint Medicines (BPMC) competitors?

Other companies in Blueprint Medicines’s space includes: Immunovant (NASDAQ:IMVT), Legend Biotech (NASDAQ:LEGN), Sarepta Therapeutics (NASDAQ:SRPT), Exact Sciences (NASDAQ:EXAS) and Ionis Pharmaceuticals (NASDAQ:IONS).

What is the forecast, or price target, for Blueprint Medicines (BPMC) stock?

Blueprint Medicines has a consensus price target of $115.57.

What is the current price for Blueprint Medicines (BPMC)?

The stock price for Blueprint Medicines (NASDAQ: BPMC) is $110.05 last updated January 17, 2025 at 7:02 PM EST.

Does Blueprint Medicines (BPMC) pay a dividend?

There are no upcoming dividends for Blueprint Medicines.

When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?

Blueprint Medicines’s Q4 earnings are confirmed for Thursday, February 13, 2025.

Is Blueprint Medicines (BPMC) going to split?

There is no upcoming split for Blueprint Medicines.

What sector and industry does Blueprint Medicines (BPMC) operate in?

Blueprint Medicines is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Comments

Blueprint Medicines

Blueprint Medicines (BPMC) Forecast

Blueprint Medicines (NASDAQ:BPMC) Stock Quotes, Forecast and News Summary

Recent News

Financials

Analyst Trends and Forecast

Analyst Rating and Forecast

Compare

FAQ

How do I buy Blueprint Medicines (BPMC) stock?

Who are Blueprint Medicines (BPMC) competitors?

What is the forecast, or price target, for Blueprint Medicines (BPMC) stock?

What is the current price for Blueprint Medicines (BPMC)?

Does Blueprint Medicines (BPMC) pay a dividend?

When is Blueprint Medicines (NASDAQ:BPMC) reporting earnings?

Is Blueprint Medicines (BPMC) going to split?

What sector and industry does Blueprint Medicines (BPMC) operate in?

People Also Watch

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga